| Literature DB >> 27830780 |
Rebecca G Canter1, Jay Penney1, Li-Huei Tsai1,2.
Abstract
Alzheimer's disease is a progressive loss of memory and cognition, for which there is no cure. Although genetic studies initially suggested a primary role for amyloid-in Alzheimer's disease, treatment strategies targeted at reducing amyloid-have failed to reverse cognitive symptoms. These clinical findings suggest that cognitive decline is the result of a complex pathophysiology and that targeting amyloid-alone may not be sufficient to treat Alzheimer's disease. Instead, a broad outlook on neural-circuit-damaging processes may yield insights into new therapeutic strategies for curing memory loss in the disease.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27830780 DOI: 10.1038/nature20412
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962